161 – 170 of 246
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Lag-times between lympho-proliferative disorder and clinical diagnosis of chronic lymphocytic leukemia (CLL): a prospective analysis using plasma soluble CD23.
(
- Contribution to journal › Article
-
Mark
General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Plasma Elaidic Acid Level as Biomarker of Industrial Trans Fatty Acids and Risk of Weight Change: Report from the EPIC Study.
(
- Contribution to journal › Article
-
Mark
Body iron status and gastric cancer risk in the EURGAST study.
(
- Contribution to journal › Article
-
Mark
Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population
(
- Contribution to journal › Article
-
Mark
Dietary intake of acrylamide and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
(
- Contribution to journal › Article
-
Mark
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition.
(
- Contribution to journal › Article
-
Mark
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study
(
- Contribution to journal › Article
-
Mark
Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)
(
- Contribution to journal › Article